Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Mar;19(2):85-8.
doi: 10.1097/ICU.0b013e3282f3919b.

Normal-tension glaucoma: is it different from primary open-angle glaucoma?

Affiliations
Review

Normal-tension glaucoma: is it different from primary open-angle glaucoma?

M Bruce Shields. Curr Opin Ophthalmol. 2008 Mar.

Abstract

Purpose of review: Normal-tension glaucoma (NTG) is a common form of open-angle glaucoma throughout the world, and yet there are many unanswered questions regarding both the mechanisms of the optic neuropathy and the treatment of these patients. The present review considers how recent literature advances our understanding of both the mechanisms of glaucomatous damage and the treatment of patients with NTG.

Recent findings: The main theme in the current literature continues to be that NTG and primary open-angle glaucoma (POAG) represent a continuum of open-angle glaucomas, in which a certain level of intraocular pressure (IOP) is the predominant causative risk factor in POAG, while additional IOP-independent factors take increasing importance in NTG. There is considerable overlap between the two conditions, however, and within the population of NTG patients there are subsets in which IOP, blood flow and other factors assume relative importance.

Summary: In clinical practice, control of IOP remains the mainstay of managing NTG patients, but consideration must also be given to other factors, especially those that may influence perfusion of the optic nerve head. Treatment paradigms will likely change as researchers continue to investigate the mechanisms of glaucomatous optic neuropathy and search for IOP-independent neuroprotective agents.

PubMed Disclaimer

MeSH terms